The clinical significance of serum Sema4D level and platelet aggregation function in patients with coronary atherosclerotic heart disease

Clinical significance of serum Sema4D level and platelet aggregation function in patients with coronary atherosclerotic heart disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ROC-17013978

Enrollment

Unknown

Registered

2017-12-15

Start date

2018-01-01

Completion date

Unknown

Last updated

2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

Case series:Nil

Sponsors

The second xiangya hospital, Central South University, Changsha, Hunan, China

Lead Sponsor

Eligibility

Sex/Gender

All

Age

40 Years to 88 Years

Inclusion criteria

Inclusion criteria: In line with the diagnosis and classification diagnosis standard of coronary heart disease in 2012 Chinese Medical Association;Coronary artery lesions detected by coronary angiography.

Exclusion criteria

Exclusion criteria: Exclusion of liver and kidney dysfunction, acute infectious diseases, cerebrovascular diseases, pulmonary embolism, pulmonary heart disease and mental illness patients

Design outcomes

Primary

Measure	Time frame
Semaohorin4D;	—

Secondary

Measure	Time frame
Blood routine, liver and kidney function, blood lipid, hs-CRP, ESR, CRP, D-Dimer, serum Sema4D, platelet aggregation function, chest X-ray and heart color Doppler ultrasound;	—

Countries

China

Contacts

Public ContactXiangyu Zhang

The Second Xiangya Hospital, Central South University

13707486860@163.com+86 13707486860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026